In studies involving hematological malignancies, Blomhoff’s lab has reported that cAMP activating factors present in the bone marrow render B-cell precursor acute lymphoblastic leukemia (ALL) cells less sensitive to DNA damage–induced apoptosis through autophagy induction and suppression of p53 [45]. This evidence concerns the gene TP53 and acute lymphoblastic leukemia.